Trial Profile
A Single-Center Randomized, Double-Blind, Placebo-Controlled Phase 1 Trial to Assess the Safety and Tolerability of Single and Multiple Daily Oral Administration of STP206 Live Biotherapeutic in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2017
Price :
$35
*
At a glance
- Drugs STP 206 (Primary)
- Indications Acute enterocolitis
- Focus Adverse reactions
- Sponsors Sigma-Tau Pharmaceuticals
- 17 Jun 2014 New trial record